Carlsmed said late Tuesday it has priced an initial public offering of 6.7 million shares at $15 each for estimated gross proceeds of about $100.5 million.
The medical technology company said its shares are expected to begin trading on the Nasdaq Global Select Market this Wednesday, under the ticker symbol "CARL." The offering is expected to close Thursday.
Carlsmed, which offers artificial intelligence-enabled personalized spine surgery, granted underwriters a 30-day option to purchase up to an additional 1 million shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.